Le Lézard
Classified in: Health
Subjects: NPT, CHI

Lucile Packard Children's Hospital Stanford Earns Accreditation from the Adult Congenital Heart Association



PALO ALTO, Calif., Oct. 5, 2017 /PRNewswire-USNewswire/ -- In recognition of its expertise in serving adults with congenital heart disease (CHD), Lucile Packard Children's Hospital Stanford's and Stanford Health Care's joint program has received accreditation as an ACHD Comprehensive Care Center from the Adult Congenital Heart Association (ACHA), a nationwide organization focused on connecting patients, family members, and health care providers to form a community of support and network of experts with knowledge of congenital heart disease CHD.    

The team of Stanford Medicine specialists with the Adult Congenital Heart Disease Program at Stanford.

Individuals with CHD, the most common birth defect diagnosed in one in 100 births, are living longer. There are now 1.4 million adults in the U.S. living with one of the many different types of congenital heart defects that range among simple, moderate, and complex.

"At Stanford we are passionate about ensuring high-quality patient-centered care for our adult congenital heart patients," said Susan Fernandes, program director of the Adult Congenital Heart Disease Program at Stanford. "The ACHA ACHD accreditation not only acknowledges our efforts but pushes us and ACHD programs across the country to pursue the ultimate goal of exceptional care that results in an excellent quality of life and normal life expectancy."

The program is a Lucile Packard Children's Hospital Stanford and Stanford Health Care collaboration, which provides a unique approach to care with a team of clinicians and cardiothoracic surgeons who specialize in caring for adolescents and adults with congenital heart disease. The program received accreditation by meeting ACHA's criteria, which include comprehensive medical services, patient resources, personnel requirements, and going through a rigorous accreditation process, both of which were developed over a number of years through a collaboration with doctors, physician assistants, nurse practitioners, nurses, and ACHD patients.

"There are now more adults than children in the U.S. with CHD," said Mark Roeder, president and CEO of ACHA. "Accreditation will elevate the standard of care and have a positive impact on the futures of those living with this disease. Coordination of care is key, and this accreditation program will make care more streamlined for ACHD patients, improving their quality of life."

About Stanford Children's Health and Lucile Packard Children's Hospital Stanford
Stanford Children's Health, with Lucile Packard Children's Hospital at its center, is the Bay Area's largest health care system exclusively dedicated to children and expectant mothers. As a top-ranked children's hospital by U.S. News & World Report, we are a leader in world-class, nurturing care and extraordinary outcomes in every pediatric and obstetric specialty. Stanford Children's Health, providing specialty care to general pediatrics, can be accessed through more than 60 locations across Northern California and 100 locations in the U.S. western region. As the pediatric and obstetric teaching hospital for the world-renowned Stanford University School of Medicine, we're cultivating the next generation of medical professionals and are at the forefront of scientific research to improve children's health outcomes around the world. We are a non-profit organization committed to supporting the community through meaningful outreach programs and services and providing needed medical care to families, regardless of their ability to pay. Discover more at stanfordchildrens.org

About the Adult Congenital Heart Association 
The Adult Congenital Heart Association (ACHA) is a national not-for-profit organization dedicated to improving the quality of life and extending the lives of adults with congenital heart disease (CHD). ACHA serves and supports the more than one million adults with CHD, their families and the medical community?working with them to address the unmet needs of the long-term survivors of congenital heart defects through education, outreach, advocacy, and promotion of ACHD research. For more information about ACHA, contact (888) 921-ACHA or visit www.achaheart.org

The ACHA ACHD Accreditation Program was partially funded by Actelion Pharmaceuticals U.S., Inc. ACHA and Actelion Pharmaceuticals have partnered together since 2007 to support the CHD community.

CONTACT                                                                
Samantha Dorman
sdorman@stanfordchildrens.org
650-498-7056

 

Lucile Packard Children's Hospital Stanford (PRNewsfoto/Lucile Packard Children's Hospi)

SOURCE Stanford Children's Health


These press releases may also interest you

at 09:01
LONDON, Oct. 18, 2017 /PRNewswire/ -- Global Organic Acids Market: Overview As the food and beverages industry is one of its key end users, the rising population worldwide and GDP growth will pique the demand for organic acids in the forthcoming...

at 09:01
LONDON, October 18, 2017 /PRNewswire/ -- Revenue Prospects by Application (Drug Discovery, Genetic Screening, Diagnostics, Personalized Medicine, Agriculture and Animal Research, Infectious Diseases, Others) Technology (Whole-Genome Sequencing,...

at 09:00
NEW YORK, Oct. 18, 2017 /PRNewswire/ -- The Blinc Group, a distribution-centric vapor and cannabis incubator, successfully closed its first financing round. With an infusion of US-based private capital, The Blinc Group intends to deploy these funds...

at 09:00
SECAUCUS, N.J., Oct. 18, 2017 /PRNewswire/ -- The Vitamin Shoppe® (NYSE: VSI), an omni-channel, specialty retailer and manufacturer of nutritional products, has introduced RangeMe to its merchandise innovation and sourcing process. The new...

at 09:00
FAIRFAX, Va., Oct. 18, 2017 /PRNewswire-USNewswire/ -- The Inova Personalized Health Accelerator (IPHA) announced today that area investor and business strategist Rick Gordon has been appointed Director. He is a proven leader with more than 25 years...

at 09:00
SAN DIEGO, Oct.18, 2017 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its subsidiary Kannaway®  LLC is welcoming Robert "Bo" Brannin as its new Senior...




News published on 5 october 2017 at 14:40 and distributed by: